Fenadol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenadol

What is Fenadol?

Fenadol is a pharmacological agent belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily utilized for its analgesic, anti-inflammatory, and antipyretic properties. The active substance in Fenadol works by inhibiting the activity of cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for the synthesis of prostaglandins—chemicals in the body that mediate pain, fever, and inflammation.

Therapeutic Use

This medication is typically indicated for the management of various conditions characterized by acute or chronic pain and inflammation. These may include:

  • Musculoskeletal disorders: Such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
  • Acute pain management: Including post-operative pain, dental pain, and primary dysmenorrhea.
  • Soft tissue injuries: Such as sprains, strains, and low back pain.

Mechanism of Action

By reducing the production of prostaglandins at the site of injury or throughout the body, Fenadol helps to alleviate the sensation of pain and decrease physical swelling. Unlike opioid analgesics, it does not induce sedation or physical dependence, as it targets the peripheral and central nervous systems through non-narcotic pathways.

Available Forms

Fenadol is produced in several formulations to accommodate different clinical needs. These common delivery methods include oral tablets, capsules, and extended-release versions designed to maintain therapeutic levels of the medication in the bloodstream over a longer duration.

What side effects are possible with Fenadol?

Official Safety Profile and Adverse Reactions

Fenadol, containing the active ingredient Diclofenac, is classified as a Non-steroidal Anti-inflammatory Drug (NSAID) and carries a documented risk profile across several physiological systems, as stated in regulatory prescribing information.

Serious Adverse Events

Regulatory documents emphasize the potential for serious cardiovascular thrombotic events, including Myocardial Infarction and Stroke, and serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms and may be fatal. Additionally, rare but life-threatening reactions like Severe Hepatic Failure and Stevens-Johnson Syndrome (SJS) are documented.

Common Adverse Reactions and System Groupings

Side effects are classified by frequency and grouped into System Organ Classes (SOCs). Common adverse reactions often involve the Gastrointestinal Disorders system, including nausea, vomiting, dyspepsia, abdominal pain, and diarrhea. Other common effects noted in the Nervous System Disorders class are headache and dizziness. The safety profile also includes effects on Hepatobiliary Disorders (e.g., elevated liver enzymes) and Renal and Urinary Disorders.

Safety Patterns and Restrictions

The risk of serious cardiovascular and gastrointestinal events is officially documented to increase with longer duration of use and higher daily dose. Specific safety considerations are noted for certain populations: Older adults have a greater risk for serious gastrointestinal complications. The medicine is contraindicated in patients with established heart failure (NYHA Class II-IV), severe renal or hepatic failure, and is generally avoided in the later stages of pregnancy due to risks to the fetus.

Overdose and Emergency Response

Overdose and when to seek help

Suspected overdose of Fenadol (Diclofenac) requires immediate medical attention. Regulatory authorities mandate that you contact emergency services or a Poison Control center right away, as no specific antidote is known for this medication.

While many documented acute overdoses are initially asymptomatic or present with minor, self-limiting symptoms such as nausea, vomiting, epigastric pain, headache, and drowsiness, the potential for severe outcomes is a primary concern.

Documented Severe Manifestations

The official prescribing information documents serious and life-threatening complications that may follow a large ingestion, including:

  • Organ System Toxicity: Acute renal failure, hepatic failure (liver necrosis), and massive gastrointestinal bleeding.
  • Neurological Effects: Convulsions (seizures) and coma.

Management and Risk

Treatment is strictly symptomatic and supportive. Procedures such as the administration of activated charcoal may be considered based on the timing and quantity of ingestion. Monitoring of renal and hepatic function is required following large exposures. Regulatory labeling notes that the elderly and individuals with asthma are at a potentially higher risk for certain adverse reactions following NSAID exposure.

Therapeutic Uses of Fenadol

What Fenadol Treats: Main Uses and Benefits

Fenadol is a pharmacological treatment primarily utilized for its analgesic (pain-relieving) and anti-inflammatory properties. It belongs to the class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). The medication is designed to manage conditions characterized by acute or chronic pain and inflammation.

Primary Therapeutic Uses

The application of Fenadol is centered on the management of musculoskeletal and inflammatory disorders. Common indications include:

  • Arthritic Conditions: Management of symptoms associated with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It helps reduce joint swelling, stiffness, and pain.
  • Acute Musculoskeletal Injuries: Relief from pain and inflammation resulting from sprains, strains, and other soft tissue injuries.
  • Post-Operative Recovery: Use in the management of inflammatory pain following surgical procedures.
  • Primary Dysmenorrhea: Relief of pain associated with menstrual cycles.

Mechanism of Action and Benefits

Fenadol works by inhibiting the enzymes responsible for the synthesis of prostaglandins, which are lipid compounds that act as mediators for pain and inflammation in the body. By reducing the concentration of these compounds at the site of injury or disease, the medication provides several clinical benefits:

  • Reduction of Edema: It assists in decreasing localized swelling caused by inflammatory responses.
  • Improved Mobility: By alleviating joint pain and stiffness, it can support a broader range of motion in patients with chronic inflammatory conditions.
  • Symptomatic Relief: It addresses the sensory experience of pain, providing comfort during the healing process or in the management of long-term degenerative conditions.

Fenadol is intended to manage symptoms and improve functional capacity; however, it does not treat the underlying cause of chronic degenerative diseases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Fenadol's regulatory profile defines clear eligibility and non-eligibility criteria based on established risks and clinical data, as documented by authoritative government health agencies.

Contraindicated Populations

Use of Fenadol is prohibited in individuals with a known hypersensitivity to the drug or any excipients. It is also contraindicated for patients with pre-existing ischaemic heart disease, cerebrovascular disease, peripheral arterial disease, severe hepatic or renal impairment, and uncontrolled hypertension.

Age and Physiological Restrictions

Population Group Regulatory Status
Infants/Children/Adolescents (Under 18) Safety and efficacy are generally not established; use is not approved for primary indications.
Older Adults (Aged 65+) Restricted use; the lowest effective dose for the shortest duration is mandated due to increased risk of adverse events.
Pregnancy (Late Gestation) Avoided/Contraindicated (e.g., after 30 weeks) due to documented fetal risk.
Lactation/Breastfeeding Not established; official recommendation is to weigh the benefits and risks, often advising discontinuation of the drug or nursing.

Condition-Based Limitations

Patients with moderate hepatic or renal impairment require conditional use, often involving specific dose adjustments and close monitoring. Use is also restricted in those with an active or recurrent history of gastrointestinal bleeding or peptic ulceration.

What should I know about interactions with other medicines?

Fenadol’s official interaction profile is structured around combinations that are either contraindicated or require significant caution as documented by regulatory authorities. The medicine is officially contraindicated for the management of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Co-administration with other systemic NSAIDs or COX-2 inhibitors is strongly discouraged due to the documented risk of additive serious adverse effects. Consumption of alcohol is restricted as it increases the risk of serious gastrointestinal (GI) adverse events, including bleeding.

Pharmacodynamic interactions establish that co-administration with Anticoagulants, Antiplatelet agents, SSRIs, or Systemic Corticosteroids is associated with an increased risk of serious GI bleeding and ulceration. Fenadol may also attenuate the antihypertensive effect of Diuretics, ACE Inhibitors, or Angiotensin Receptor Blockers (ARBs), potentially resulting in the deterioration of renal function. This renal risk is officially noted as heightened in the elderly or volume-depleted patients.

Regarding exposure, the strong inhibitor Voriconazole is documented to significantly increase the plasma concentration (AUC) of Diclofenac via CYP2C9 inhibition. Conversely, Fenadol may increase the serum concentrations of substances like Digoxin and Lithium due to reduced renal clearance. Specific immediate-release formulations are officially recommended to be taken on an empty stomach as food may reduce effectiveness.

Mechanism of Action

Molecular Mechanism: COX Enzyme Inhibition

Fenadol's primary action involves the inhibition of Cyclooxygenase (COX) enzymes, particularly COX-2, by non-covalently blocking the active site where Arachidonic Acid binds. This key step halts the first stage of the prostaglandin synthesis pathway, directly preventing the formation of PGE2 and other prostanoids. This molecular interference modifies the early signaling steps that shape systemic physiological outcomes.


Central and Peripheral Pathway Modulation

The resulting decrease in prostaglandins exerts two major physiological effects: Peripherally, it lessens the sensitization of nociceptors (sensory afferents) and reduces vascular permeability, contributing to the reduction of localized vascular changes and sensitization. Centrally, the inhibition of PGE2 synthesis within the hypothalamus allows the body's elevated temperature set-point to return toward its homeostatic set-point, leading to resultant physiological changes in thermoregulation.


Mechanism Boundaries

While Fenadol's action is primarily focused on suppressing overactive signaling mediators, it does not interact with the biological pathways responsible for structural remodeling. Furthermore, the mechanistic effect is constrained in physiological states that are not primarily driven by the prostaglandin pathway.

Dosage and Administration Information

Administration Methods

Fenadol is typically available in various formulations, including oral tablets, capsules, and topical applications. The method of administration depends on the specific form prescribed. Oral versions are generally taken with a full glass of water. For those with sensitive stomachs, taking the medication alongside food or milk may assist with gastrointestinal comfort.

Timing and Consistency

Maintaining a regular schedule helps ensure a consistent level of the medication remains in the bloodstream. It is common practice to space applications or doses at even intervals throughout the day. If a specific schedule is established, following it consistently is a standard part of the routine.

Proper Handling and Storage

To maintain the integrity of the medication, it should be kept in its original packaging until the time of use. This protects the product from environmental factors such as light and moisture.

Storage Environment

  • Keep the medication at room temperature.
  • Store in a dry location away from direct heat.
  • Ensure the storage area is secure and out of reach of children or pets.

Form-Specific Considerations

Extended-Release Formulations

Certain versions of Fenadol are designed to release the active ingredient slowly over an extended period. These are intended to be swallowed whole. Altering the physical structure of these tablets, such as crushing or chewing them, can interfere with the intended release mechanism.

Topical Applications

When using topical forms, the area of skin should be clean and dry before application. A thin layer is usually applied to the affected area as directed. It is advisable to wash hands thoroughly after application to avoid accidental contact with sensitive areas like the eyes or mouth.

Recent Clinical Evidence

Research evidence / Overview of Studies for Fenadol

Evidence for Pain Management in Joint Conditions

The research base for Fenadol's studied use in chronic joint conditions, such as osteoarthritis and rheumatoid arthritis, often includes evidence from Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies primarily evaluated outcomes related to physical discomfort and functional imbalance. In both oral and topical formulations, studies were used in research exploring how symptoms change over time, typically tracking patients over short- to intermediate-term follow-up durations (up to three months). The research examined patient-reported outcomes describing perceived discomfort using standardized scales, alongside measures of joint stiffness and assessments of physical function.

Studies Focused on Chronic Joint Pain and Stiffness

Findings describe patterns observed in studies related to changes in pain scores and outcomes related to movement. The research for chronic joint conditions is relevant in evidence describing how symptoms are measured over defined time intervals. Results related to the long-term effects on the conditions themselves are less commonly the focus of the primary trials, necessitating reliance on observational settings evaluating daily-life functioning.


Evidence for Treatment of Acute Symptoms

Fenadol was also studied for conditions associated with acute or disruptive episodes. This includes research examining symptoms experienced during acute migraine attacks, gout flares, and localized discomfort from minor injuries or post-operative pain. These research scenarios were conducted during periods of increased symptom activity and utilize fast-acting formulations.

Research on Rapid Symptom Change

The trials exploring rapid symptom change are mostly placebo-controlled RCTs. The outcomes monitored included the time required to notice a change in symptom intensity and the sustained duration of that change. Studies observed responses over time intervals of hours to days, and the data suggest patterns related to symptomatic change, but are limited to the immediate episode.


What is Still Uncertain About Fenadol Research

The research landscape includes many studies for short-term symptomatic use, but contains several research limitation frames. Follow-up durations were limited in many pivotal trials, meaning research provides context but not individual predictions for long-term usage. Long-term effects are not fully established, and evidence is limited for certain groups, requiring careful regulatory oversight of the existing information.

Key Studies & References

  1. Diclofenac-potassium in migraine: a review

Frequently Asked Questions (FAQ)

Common questions about Fenadol (FAQ)

Q: What is the main reason doctors prescribe Fenadol?

A: Fenadol (Diclofenac) is officially indicated for symptomatic relief from pain and inflammation. The regulatory documents list its approved uses for managing symptoms of chronic joint conditions, such as osteoarthritis and rheumatoid arthritis, as well as for treating various types of acute pain.

Q: Can Fenadol be taken with common over-the-counter pain medications?

A: Official information advises against combining Fenadol with other Non-steroidal Anti-inflammatory Drugs (NSAIDs) because this combination increases the risk of documented serious side effects. However, in the regulatory documents, common pain relievers that are not NSAIDs, such as Acetaminophen (Paracetamol), are typically not restricted in the same manner as NSAIDs.

Q: Does Fenadol interact with common supplements like vitamins or herbal remedies?

A: Regulatory documents prioritize listing clinically significant interactions with prescription medications. Information regarding interactions with all dietary supplements may not be routinely documented in the core regulatory prescribing information. The official interaction profile is structured around specific pharmaceuticals that are known to significantly affect the medicine’s concentration or risk profile.

Q: What if Fenadol doesn't seem to be working after the first few days?

A: The time it takes to see a change in symptoms can depend on the specific formulation of Fenadol and the condition it is addressing. Patients are generally directed to use the lowest effective dose for the shortest possible duration. If the medicine does not provide the expected relief, patients may wish to discuss their condition with a healthcare provider.

Q: What should a patient look out for as an early sign of a serious side effect from Fenadol?

A: Official warnings describe specific physical signs associated with serious adverse events. For instance, signs of gastrointestinal bleeding can include stomach pain, passing black or tarry stools, or vomiting material that resembles coffee grounds. Signs of liver problems may involve yellowing of the skin or eyes. These documented symptoms are noted as requiring prompt review by a healthcare professional.

Q: Is Fenadol used for chronic conditions or only short-term problems?

A: Regulatory documents indicate that Fenadol is officially approved for managing the symptoms of both chronic and acute conditions. Specific formulations are approved for use in long-term conditions like certain types of arthritis, while others are designated for short-term management of acute pain episodes.

Q: Can I drive or operate machinery after taking Fenadol?

A: Official product information notes that Fenadol may cause side effects such as dizziness, drowsiness, or visual disturbances. Official documentation states that individuals experiencing such effects should avoid driving or operating machinery until the symptoms have fully resolved.

Q: Does Fenadol cause weight gain or loss?

A: Official safety documents list adverse effects related to fluid retention, or edema, which can be associated with weight change. Additionally, unusual weight gain or swelling is listed as a potential indicator of a more serious side effect affecting the heart or kidneys, as detailed in the warnings section of the regulatory information.

Q: How long does it usually take for Fenadol to start working?

A: The time it takes for relief to begin depends on the specific form of Fenadol being used. For some rapid-release formulations, the onset of action may be relatively fast, possibly within an hour. For chronic treatment, the official information indicates that a period of consistent use is often needed to achieve the full symptomatic benefit.

Q: Is it possible to become dependent on Fenadol?

A: Regulatory safety information lists Fenadol as a Non-steroidal Anti-inflammatory Drug (NSAID). Based on the official product labeling and classification, there is no documented potential for dependence, abuse, or addiction associated with the use of Fenadol.

Q: Can Fenadol cause changes in mood or anxiety levels?

A: Official regulatory documents include mood changes and certain psychological reactions in the list of possible adverse effects. These documented reactions include reports of irritability, nervousness, anxiety, and depression.

Q: What is the recommended duration of treatment with Fenadol?

A: The total duration of treatment is determined by the specific condition being addressed. Across all uses, the official, mandated guideline is to use the lowest effective dose for the shortest possible duration to minimize the documented risks associated with longer treatment.

Q: Is it normal to feel a mild dizziness after taking Fenadol?

A: Dizziness is documented in official safety information as a common adverse reaction that can be experienced by users. Regulatory documents note that if dizziness occurs, it is advised to avoid driving or operating machinery while the effect is present.

Q: What happens if a dose of Fenadol is forgotten?

A: Patient information generally provides guidance for missed doses. It typically indicates that if a dose is missed, it can be taken when remembered, unless it is close to the time for the next scheduled dose. If it is almost time for the next dose, the missed dose should be skipped to prevent accidentally taking two doses too close together.

Q: Does Fenadol affect your sleep?

A: Official safety data includes insomnia, or difficulty sleeping, as a documented adverse reaction that has been reported by users. If sleep disturbances are noted during use, they are listed as a possible side effect of the medicine.

Q: Can using Fenadol affect blood sugar levels?

A: Regulatory documents advise that caution is needed for patients with certain pre-existing conditions, including diabetes. Some regulatory information notes that Fenadol has the potential to affect blood sugar levels, listing hyperglycemia (high blood sugar) as a possible adverse effect.

Q: Are vision changes ever linked to Fenadol use?

A: Yes, visual disturbances are included in the adverse reactions section of the official product information. Reports of blurred vision or changes in sight are documented as potential effects.

Q: Can Fenadol make you more sensitive to the sun?

A: Official regulatory documentation states that photosensitivity reactions, which is an increased sensitivity to strong sunlight, have been reported with Fenadol use. Official documentation states that precautions against sun exposure, such as using protective clothing or sunscreen, are noted as being important when using this medicine.

Q: Why do some people say Fenadol is hard to get?

A: Fenadol (Diclofenac) has undergone regulatory reclassification in some regions due to an evaluation of potential cardiovascular side effect risks. As a result, its status was changed from an over-the-counter medicine to a prescription-only medicine, requiring authorization from a healthcare provider for supply.

Q: Why is it important to know who cannot use Fenadol?

A: It is critical because regulatory documentation emphasizes that using the medicine in patients with specific severe conditions, such as established heart failure, uncontrolled hypertension, or a history of GI bleeding, significantly increases the risk of documented serious adverse events. These contraindications are mandated by regulatory authorities to prevent serious harm.

Q: Do studies suggest Fenadol is better taken in the morning or at night?

A: Official instructions specify the total daily dose and how often the drug should be taken, which is often tied to food intake (with or without meals). Unless the product is a once-daily, extended-release formulation designed for 24-hour coverage, official regulatory documents do not typically mandate a specific time of day like morning versus night.

How should Fenadol be stored and disposed of?

Storage and Disposal of Fenadol

Fenadol (Diclofenac) must be stored under specific environmental controls to maintain product stability and efficacy, as defined by regulatory labeling.


Storage Conditions

Requirement Description
Temperature Store at room temperature, typically not exceeding 30°C. Keep from freezing or excessive heat.
Protection Keep the medicine away from moisture and direct light. Store in the original, closed container.
Child Safety It is mandatory to keep out of the reach of children.

Disposal Instructions

Discard unused or expired product according to local regulations. Medicines should generally not be disposed of by flushing them down the toilet or placing them in household waste; consult a professional for proper disposal guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fenadol found in:

A-Z Index: